Tech Company Financing Transactions

Cumulus Oncology Funding Round

Eos Advisory, The Scottish National Investment Bank and private investors invested in a $11.4 million Seed funding round for Cumulus Oncology. The funding round was announced by the company on 1/8/2024.

Transaction Overview

Company Name
Announced On
1/8/2024
Transaction Type
Venture Equity
Amount
$11,440,000
Round
Seed
Investors

Eos Advisory (Lead Investor)

The Scottish National Investment Bank (Lead Investor)

Proceeds Purpose
The company intends to use the funds to execute growth plans, expand its portfolio, and accelerate the development of new cancer treatments from discovery towards clinical Proof of Concept.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
WeWork, 80 George Street
Edinburgh, EH2 3BU
UK
Phone
Undisclosed
Email Address
Not Recorded
Overview
Europe's first oncology biotech creation studio, Cumulus Oncology was founded by Dr Clare Wareing (CEO) in 2017. Underpinning the creation of Cumulus was the evident inherent redundancy in the traditional biotech model. Cumulus companies are managed to key value inflection points and assigned team members appropriate to the scientific area and development stage of each company.
Profile
Cumulus Oncology LinkedIn Company Profile
Social Media
Cumulus Oncology Company Twitter Account
Company News
Cumulus Oncology News
Facebook
Cumulus Oncology on Facebook
YouTube
Cumulus Oncology on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Clare Wareing
  Clare Wareing LinkedIn Profile  Clare Wareing Twitter Account  Clare Wareing News  Clare Wareing on Facebook
Chief Financial Officer
James Fair
  James Fair LinkedIn Profile  James Fair Twitter Account  James Fair News  James Fair on Facebook
Chief Operating Officer
Clare Doris
  Clare Doris LinkedIn Profile  Clare Doris Twitter Account  Clare Doris News  Clare Doris on Facebook
Chief Scientific Officer
Ian Waddell
  Ian Waddell LinkedIn Profile  Ian Waddell Twitter Account  Ian Waddell News  Ian Waddell on Facebook
VP - Bus. Development
Tim Sparey
  Tim Sparey LinkedIn Profile  Tim Sparey Twitter Account  Tim Sparey News  Tim Sparey on Facebook
VP - Finance
Scott Doak
  Scott Doak LinkedIn Profile  Scott Doak Twitter Account  Scott Doak News  Scott Doak on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/8/2024: Mush Foods venture capital transaction
Next: 1/8/2024: Hi.health venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary